Action of androgens versus estrogens in male skeletal homeostasis

Bone

Volumn 23, Issue 5, 1998, Pages 391-394

  Vanderschueren, D ^a   Boonen, S ^a   Bouillon, R ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR; TESTOSTERONE;

ANDROGEN METABOLISM; BONE ATROPHY; BONE DENSITY; BONE METABOLISM; ESTROGEN ACTIVITY; HOMEOSTASIS AND REGULATION; HUMAN; PUBERTY; REVIEW; SKELETON; TRABECULAR BONE;

ANDROGENS; ANIMALS; BONE AND BONES; BONE DENSITY; ESTROGENS; HOMEOSTASIS; HUMANS; MALE; RECEPTORS, ANDROGEN;

EID: 0031683631     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(98)00131-8     Document Type: Review

References (40)

1. Abu E.O., Horner A., Kusec V., Triffitt J.T., Compston J.E. The localization of androgen receptors in human bone. J Clin Endocrinol Metab. 82:1997;3493-3497.
2. Anderson F.H., Francis R.M., Peaston R.T., Wastell H.J. Androgen supplementation in eugonadal men with osteoporosis Effects of six months' treatment on markers of bone formation and resorption . J Bone Miner Res. 12:1997;472-478.
3. Bellido T., Jilka R.L., Boyce B.F., Girasole G., Broxmeyer H., Dalrymple S.A., Murray R., Manolagas S.C. Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens The role of the androgen receptor . J Clin Invest. 95:1995;2886-2895.
4. Bodine P.V.N., Riggs B.L., Spelsberg T.C. Regulation of c-fos expression and TGF-β production by gonadal and adrenal androgens in normal human osteoblastic cells. J Ster Biochem Mol Biol. 52:1995;149-158.
5. Broulik P.D., Starka L. Effect of antiandrogens Casodex and epitestosterone on bone composition in mice. Bone. 20:1997;473-475.
6. Carani C., Qin K., Simoni M., Faustini-Fustini M., Serpente S., Boyd J., Korach K.S., Simpson E.R. Effect of testosterone and estradiol in a man with aromatase deficiency Brief report . N Engl J Med. 337:1997;91-95.
7. Colvard D.S., Eriksen E.F., Keeting P.E., Wilson E.M., Lubahn D.B., French F.S., Riggs B.L., Spelsberg T.C. Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci USA. 86:1989;854-857.
8. Dagogo-Jack S., Al-Ali N., Qurttom M. Augmentation of bone mineral density in hirsute women. J Clin Endocrinol Metab. 82:1997;2821-2825.
9. Eriksen E.F., Colvard D.S., Berg N.J., Graham M.L., Mann K.G., Spelsberg T.C., Riggs B.L. Evidence of estrogen receptors in normal human osteoblast-like cells. Science. 241:1988;84-86.
10. Goldray D., Weisman Y., Jaccard N., Merdler C., Chen J., Matzin H. Decreased bone density in elderly men treated with the gonadotropin-releasing hormone agonist Decapeptyl. J Clin Endocrinol Metab. 76:1993;288-290.
11. Goulding A., Gold E. Flutamide-mediated androgen blockade evokes osteopenia in the female rat. J Bone Miner Res. 8:1993;763-769.
12. Greendale G.A., Edelstein S., Barrett-Connor E. Endogenous sex steroids and bone mineral density in older women and men The Rancho Bernardo Study . J Bone Miner Res. 12:1997;1833-1843.
13. Khosla S., Melton L.J. III, Atkinson E.J., Riggs B.L. Serum estrogen levels, rather than serum testosterone levels, are the major determinants of decreases in bone mineral density in aging men Programs & Abstracts of the ASBMR 19th Annual Meeting, Cincinnati, Ohio [abstract] . J Bone Miner Res. 12:(Suppl. 1):1997;97.
14. Korach, K. S., Couse, J. F., Curtis, S. W., Washburn, T. F., Lindzey, J., et al. Estrogen receptor gene disruption: Molecular characterization and experimental and clinical phenotypes. Recent Prog Horm Res 51:159-186, 186-188; 1996.
15. Lea C.K., Flanagan A.M. Physiological plasma levels of androgens reduce bone loss in the ovariectomized rat. Am J Physiol. 274:1998;E328-E335.
16. Lips P., Asscheman H., Uitewaal P., Netenbos J.C., Gooren L. The effect of cross-gender hormonal treatment on bone metabolism in male-to-female transsexuals. J Bone Miner Res. 4:1989;657-662.
17. Manolagas S., Bellido T., Jilka R. Sex steroids, cytokines and the bone marrow New concepts on the pathogenesis of osteoporosis . Non-Reproductive Actions of Sex Steroids (Ciba Foundation Symposium 191). 1995;187-202 Wiley, Chichester.
18. Matzkin H., Chen J., Weisman Y., Goldray D., Pappas F., Jaccard N., Braf Z. Prolonged treatment with finasteride (a 5α-reductase inhibitor) does not affect bone density and metabolism. Clin Endocrinol. 37:1992;432-436.
19. Millard W.J., Politch J.A., Martin J.B., Fox T.O. Growth hormone secretory patterns in androgen-resistant (testicular feminized) rats. Endocrinology. 119:1986;2655-2680.
20. Mooradian A.D., Morley J.E., Korenman S.G. Biological actions of androgens. Endocrin Rev. 8:1987;1-27.
21. Morishima A., Grumbach M.M., Simpson E.R., Fisher C., Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab. 80:1995;3689-3698.
22. Muñoz-Torres M., Jódar E., Quesada M., Escobar-Jiménez F. Bone mass in androgen-insensitivity syndrome Response to hormonal replacement therapy . Calcif Tissue Int. 57:1995;94-96.
23. Raisz L.G., Wiita B., Artis A., Bowen A., Schwartz S., Trahiotis M., Shoukri K., Smith J. Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Clin Endocrinol Metab. 81:1996;37-43.
24. Rosen H.N., Tollin S., Balena R., Middlebrooks V.L., Moses A.C., Yamamoto M., Zeind A.J., Greenspan S.L. Bone density is normal in male rats treated with finasteride. Endocrinology. 136:1995;1381-1387.
25. Saito H., Yanaihara T. Steroid formation in osteoblast-like cells. J Int Med Res. 26:1998;1-12.
26. Sasano H., Uzuki M., Sawai T., Nagura H., Matsunaga G., Kashimoto O., Harada N. Aromatase in human bone tissue. J Bone Miner Res. 12:1997;1416-1423.
27. Schweikert H.U., Rulf W., Niederle N., Schafer, Keck E., Kruck F. Testosterone metabolism in human bone. Acta Endocrinol. 95:1980;258-264.
28. Seeman E. Advances in the study of osteoporosis in men. Meunier P.J. Osteoporosis Diagnosis and Management . 1998;211-232 Dunitz, London.
29. Smith E.P., Boyd J., Frank G.R., et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 331:1994;1056-1061.
30. Stepan J.J., Lachman M., Zverina J., Pacovscky V., Baylink D.J. Castrated men exhibit bone loss Effect of calcitonin treatment on biochemical indices of bone remodeling . J Clin Endocrinol Metab. 69:1989;523-527.
31. Taki M., Kimbro K.S., Washburn T.F., Kiyokawa A., Okada F., Fukuda C., Miyamoto M., Korach K.S. Effects of estrogen receptor destruction on femurs from male mice Programs & Abstracts of the ASBMR 19th Annual Meeting, Cincinnati, Ohio [abstract] . J Bone Miner Res. 12:(Suppl. 1):1997;S430.
32. Turner R.T., Bleriberg B.B., Colvard D.S., Keeting P.E., Evans G., Spelsberg T.C. Failure of isolated rat tibial periosteal cells to 5 alfa-reduce testosterone to 5 alfa-dihydrotestosterone. J Bone Miner Res. 5:1990;775-779.
33. Vanderschueren D., Bouillon R. Editorial Review Androgens and bone . Calcif Tissue Int. 56:1995;341-346.
34. Vanderschueren D., Van Herck E., De Coster R., Bouillon R. Aromatization of androgens is important for skeletal maintenance of aged male rats. Calcif Tissue Int. 59:1996;179-183.
35. Vanderschueren D., Van Herck E., Ederveen A.G.H., De Coster R., Bouillon R. Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing rats. Endocrinology. 138:1997;2301-2307.
36. Vanderschueren D., Van Herck E., Geusens P., Suiker A., Visser W., Chung K., Bouillon R. Androgen resistance and deficiency have different effects on the growing skeleton of the rat. Calcif Tissue Int. 55:1994;198-203.
37. Vanderschueren D., Van Herck E., Nijs J., Ederveen A.G.H., De Coster R., Bouillon R. Estrogens prevent the effect of aromatase inhibition on the skeleton of aged male rats Programs & Abstracts ASBMR of the 19th Annual Meeting, Cincinnati, Ohio [abstract] . J Bone Miner Res. 12:(Suppl. 1):1997;T483.
38. Vanderschueren D., Van Herck E., Suiker A.M.H., Visser W.J., Schot L.P.C., Bouillon R. Bone and mineral metabolism in aged male rats Short and long term effects of androgen deficiency . Endocrinology. 130:1992;2906-2916.
39. Vanderschueren D., Van Herck E., Suiker A.M.H., Visser W.J., Schot L.P.C., Chung K., Lucas R.S., Einhorn T.A., Bouillon R. Bone and mineral metabolism in the androgen-resistant (testicular feminized) male rat. J Bone Miner Res. 8:1993;801-809.
40. Vered I., Kaiserman I., Sela B.-A., Sack J. Cross genotype sex hormone treatment in two cases of hypogonadal osteoporosis. J Clin Endocrinol Metab. 82:1997;576-578.